Hemodynamic response and safety of vasodilator stress cardiovascular magnetic resonance in patients with permanent pacemakers or implantable cardioverter‐defibrillators

摘要

Abstract Introduction Vasodilator stress cardiovascular magnetic resonance (CMR) is a powerful diagnostic modality, but data toward its use in patients with permanent pacemakers (PPMs) or implantable cardioverter‐defibrillators (ICDs) is limited. Methods and Results Patients with ICDs (>1 pacing) or PPMs who underwent regadenoson single photon emission computed tomography (SPECT) and all patients with ICDs or PPMs who underwent stress CMR were retrospectively identified. SPECT tests were analyzed for hemodynamic responses and new pacing requirements; CMR studies were examined for safety, device characteristics and programming, hemodynamic responses, and image quality. Changes from baseline were evaluated with the Related‐Samples Wilcoxon Signed Rank Test. Of 67 patients (median age 65 IQR 58–72 years, 31 46 female, 31 46 Black), 47 underwent SPECT and 20 CMR. With regadenoson SPECT, 89 of patients experienced tachycardic responses above resting heart rates (+19 13–32 beats per minute, p?